Every trade that managers of LCYT disclose to TWSE / TPEx (MOPS) is tracked on this page. 1 insider has disclosed 2 filings since 18 October 2025.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
No insider has bought LCYT shares on the open market in the past twelve months.
For context, the typical company on the same exchange (median of 515 companies) published 2 filings over the same period, against 2 filings here.
Every figure here comes from the filings published by TWSE / TPEx (MOPS) and describes the past, not future prices; it is not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
2 of 2 declarations
榮科 is a company listed on the XTAI market, specializing in the technology sector. It focuses on developing innovative solutions for various industries.